Related Experiment Videos
Cloning, characterization, and expression of human LIG1
1Department of Radiation Sciences, Umeå University, Umeå, SE-90187, Sweden.
Biochemical and Biophysical Research Communications
|June 21, 2001
Summary
Researchers identified human LIG1, a homolog of Drosophila Kekkon-1, which may act as a tumor suppressor. This gene is involved in regulating growth factor signaling and is located in a cancer-associated deletion region.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- Growth factor receptors are often amplified and over-expressed in human cancers.
- A Drosophila protein, Kekkon-1, regulates epidermal growth factor (EGF) signaling via negative feedback.
- Kekkon-1 binds to the EGF receptor, inhibiting its signaling pathway.
Purpose of the Study:
- To identify human genes homologous to Drosophila Kekkon-1.
- To investigate the potential role of the identified human gene in cancer.
Main Methods:
- Homology search for Kekkon-1 in human genes.
- Gene localization analysis to chromosome band 3p14.
- mRNA expression analysis across various human tissues.
Main Results:
- Human LIG1 gene identified as a homolog of Kekkon-1.
- LIG1 is located on chromosome 3p14, a region frequently deleted in cancers.
- LIG1 mRNA is expressed in all analyzed tissues, with significant variations between brain and spleen.
- LIG1 is predicted to encode a transmembrane cell-surface protein.
Conclusions:
- LIG1 may function as a tumor suppressor in human tissues.
- The gene's location and predicted structure suggest a role in regulating cell growth and signaling.
- Further research is warranted to elucidate LIG1's precise function in cancer development.